Background Adipocytokines may play a role in fetal programming of neurodevelopment. We aimed to investigate the associations between cord blood adipocytokine concentrations and children's intelligence test scores.
Introduction
Leptin and adiponectin are peptide hormones secreted by adipose tissue and the placenta that play a role in metabolism and possibly neurodevelopment (Masuzaki et al., 1997; Chen et al., 2006;  the brain, and leptin acts in multiple brain regions that are important for cognition (Funahashi et al., 2003; Farr et al., 2006; Oomura et al., 2006; Morrison, 2009 ). In mice, short-term leptin infusions improved memory and learning (Farr et al., 2006; Oomura et al., 2006) . In contrast, high leptin levels can lead to leptin resistance in the brain, which may impair cognition (Morrison, 2009; Fadel et al., 2013) . Adiponectin, an anti-inflammatory cytokine, interacts with the brain by modulating inflammatory responses (Arnoldussen et al., 2014) . Decreases in adiponectin may increase pro-inflammatory cytokine concentrations, which could lead to neuroinflammation and subsequent cognitive impairments (Kasper et al., 2018) . In rodents, adiponectin is shown to have neuroprotective effects (Nishimura et al., 2008; Jeon et al., 2009; Ng and Chan, 2017) .
Animal studies have shown that adipocytokines may play an important role in fetal neurodevelopment (Udagawa et al., 2007) . Few epidemiologic studies have examined the impact of fetal adipocytokines on neurodevelopment, and the findings are inconclusive. Two studies found that fetal leptin was inversely associated with the risk of neurobehavioral problems in children, with one study reporting sex-specific associations (Lesseur et al., 2014; Minatoya et al., 2018) . In contrast, a cross-sectional study found that plasma leptin concentrations were associated with lower cognitive scores among infants at age 6-24 months (Camargos et al., 2017) . However, most of these studies had limitations, including small or modest sample sizes, cross-sectional design, or neurobehavioral assessment only in infancy. Thus, it is not clear if adipocytokines impact neurobehavioral outcomes later in life, specifically cognition, which tends to stabilize later in childhood and is an important determinant of school performance and later life success (Kuncel et al., 2004) .
To address these gaps in the literature and further explore the role of adipocytokines in the fetal programming of neurodevelopment, we investigated the associations between cord blood adipocytokine concentrations and children's cognitive abilities in two similarly-designed prospective studies.
Methods
We used data from two prospective pregnancy-birth cohorts in North America: the Maternal-Infant Research on Environmental Chemicals (MIREC) Study and the Health Outcomes and Measures of the Environment (HOME) Study (Arbuckle et al., 2013; Braun et al., 2017) . The two studies are similar in design and data collection strategies. All study protocols were approved by the institutional review boards of their participating institutions and participating mothers provided written informed consent for themselves and their children.
Study participants
The MIREC Study enrolled 2001 pregnant women in the first trimester of pregnancy from 10 cities (11 study sites) across Canada from 2008 to 2011 (Arbuckle et al., 2013) . Inclusion criteria, recruitment, and follow-up have been described previously (Arbuckle et al., 2013) . A total of 1861 mothers had singleton live births. We conducted in-home visits with participating children around age 3 years to measure children's neurodevelopment. Owing to limited resources, the in-person assessment was conducted on 808 children from seven study sites.
The HOME Study recruited pregnant women in the second trimester of pregnancy from the greater Cincinnati, Ohio area (United States) from [2003] [2004] [2005] [2006] . Inclusion criteria, recruitment, and follow-up have been described previously (Braun et al., 2017) . Of 468 women enrolled, 389 women remained in the study and had singleton live births. We conducted follow-up visits with participating children at ages 4 weeks and 1, 2, 3, 4, 5, and 8 years.
The current analysis was restricted to 429 children from the MIREC Study and 183 children from the HOME Study who had data available for cord blood leptin and adiponectin concentrations, covariates, and at least one measurement of full-scale intelligence quotient (FSIQ) at age 3 years (MIREC Study) or ages 5 or 8 years (HOME Study).
Cord blood adipocytokine measurement
In the MIREC Study, we measured leptin and adiponectin concentrations in umbilical cord plasma samples using an enzyme-linked immunosorbent assay (ELISA) (Meso Scale Discovery, USA) at Mt Sinai Laboratory (Ontario, Canada). We performed repeated analyses of samples when coefficients of variation (CVs) were greater than 15%. The inter-and intra-assay CVs were < 12% for leptin and < 10% for adiponectin. The limit of detections (LODs) were 0.04 ng/mL for leptin, and < 0.005 μg/mL for adiponectin. All participant samples had concentrations above the LODs.
In the HOME Study, we measured leptin and adiponectin concentrations in umbilical cord serum samples using an ELISA assay and BioTeck microtiter ELx 808 plate reader. Each analytic batch included reagent blanks and low-and high-concentration quality control (QC) samples. The CVs of repeated QC measurements for leptin and adiponectin were approximately 11% and 17%, respectively. The LODs were 0.8 ng/mL and < 2 μg/mL, for leptin and adiponectin, respectively. All samples were above the LOD for adiponectin. Seven samples were below the LOD for leptin, and the machine values were used.
Cognitive outcomes
In both studies, trained examiners assessed children's cognitive abilities using either the Wechsler Preschool and Primary Scales of Intelligence-III (WPPSI-III) or Wechsler Intelligence Scale for Children-IV (WISC-IV) test, based on children's age (Wechsler, 2002 (Wechsler, , 2003 . The two tests assess children's overall intellectual abilities (FSIQ); verbal abilities (Verbal IQ [VIQ], WPPSI-III and Verbal Comprehension Index [VCI], WISC-IV); interpretation, reasoning, and organization of visually presented nonverbal information (Performance IQ [PIQ], WPPSI-III and Perceptual Reasoning Index [PRI], WISC-IV); and speed of mental and graphomotor processing (Processing Speed Quotient [PSQ], WPPSI-III and Processing Speed Index [PSI], WISC-IV). We measured attention, concentration, and working memory for verbal material (Working Memory Index [WMI]) using the WISC-IV. The scores of FSIQ, VIQ, PIQ, and PSQ from the WPPSI-III are comparable to the scores of FSIQ, VCI, PRI, and PSI from the WISC-IV, respectively (Wechsler, 2002 (Wechsler, , 2003 . FSIQ and component scores were calculated based on Canadian (MIREC) or U.S. (HOME) population-based normative reference data. Standardized scores on these tests have a mean of 100 and standard deviation (SD) of 15 (Wechsler, 2002 (Wechsler, , 2003 . Higher scores indicate better cognitive abilities.
In the MIREC Study, we administered the WPPSI-III during an inhome visit when children were at approximately age 3 years. Study staff made their best attempts to control and standardize the environment, by ensuring the test area in the home was quiet, free from distractions, and well-lit. In the HOME Study, we administered the WPPSI-III and WISC-IV at our study clinic when children were approximately 5 and 8 years old, respectively.
Covariate assessment
We identified potential confounders of our exposure-outcome association based on a directed acyclic graph ( Figure S1) . In both studies, maternal age, marital status, education, household income, parity number, gestational alcohol consumption, length of breastfeeding, and children's race were assessed using standardized interviews. Children's sex, birth weight, gestational age, and delivery mode were abstracted from hospital medical charts. Maternal gestational impaired glucose tolerance or diabetes were assessed based on diagnosis or glucose tolerance test results abstracted from hospital medical charts. We calculated pre-pregnancy body mass index (BMI) using the self-reported weight/height, and imputation for some mothers in the HOME Study with missing data (van der Laan et al., 2007) . We calculated gestational weight gain by taking the difference between weight at last visit prior to delivery and self-reported pre-pregnancy weight, and converting it to weight gain for gestational age z-scores according to pre-pregnancy BMI categories (Hutcheon et al., 2013) . We measured children's weight and height during follow-up visits when cognition was assessed and calculated children's BMI z-scores based on World Health Organization ageand sex-specific standard data (World Health Organization Multicentre Growth Reference Study Group, 2006) . Study staff completed the Home Observation for Measurement of the Environment to assess the caregiving environment at ages 3 years (MIREC) and 12 months (HOME) (Caldwell and Bradley, 2003) . Using maternal plasma (MIREC) or serum (HOME) cotinine concentrations, we assessed, gestational tobacco smoke exposure. We assessed mothers' FSIQ in the HOME Study, using the Wechsler Abbreviated Scale of Intelligence (Wechsler, 1999) .
Statistical analyses
For both studies, we calculated children's mean FSIQ scores by categories of each covariate, and compared the FSIQ scores across these categories using the one-way analysis of variance test. We also calculated median concentrations of leptin and adiponectin by categories of each covariate, and compared adipocytokine concentrations across covariate categories using the Kruskal-Wallis test.
In the MIREC Study, we analyzed the associations between continuous adipocytokine concentrations and cognitive test score using multivariable linear regression models, with each exposure (leptin, adiponectin) and outcome (FSIQ, VIQ, PIQ) modeled separately. In the HOME Study, we analyzed these associations using a similar approach, but used linear mixed models given that the outcomes were measured repeatedly at ages 5 and 8. We also examined the associations of adipocytokines with PSQ and WMI composite scores in the HOME Study using linear regression.
Adipocytokine concentrations were log 2 -transformed in all analyses. We adjusted for maternal age, education, marital status, pre-pregnancy BMI, parity, and children's sex, race, length of breastfeeding in all multivariable models. Maternal FSIQ was only assessed and adjusted for in the HOME Study. We also adjusted for children's age at cognitive assessment in the linear mixed models. Finally, we examined the shape of the associations between adipocytokines and cognition using 3-knot restricted cubic polynomial splines (Desquilbet and Mariotti, 2010) .
Secondary and sensitivity analyses
We included adipocytokine x sex interaction terms in our models to determine whether associations between adipocytokines and cognition were modified by child sex and considered p-values for interaction terms < 0.2 to indicate the association varied by sex. We additionally adjusted for gestational age, delivery mode, birth weight percentile (calculated based on Canadian or U.S. population) (Kramer et al., 2001; Oken et al., 2003) , gestational smoking and alcohol consumption, gestational weight gain (Gage et al., 2013; Hutcheon et al., 2013) , children's BMI z-score at cognitive assessment, household income, and caregiving environment, given that the presence or directionality of the associations of some of these covariates with exposure and outcome is unclear. Finally, we conducted a sensitivity analysis excluding motherchild pairs with gestational impaired glucose tolerance or diabetes, since children that were born to mothers with gestational diabetes may have metabolic abnormalities and adverse neurodevelopment outcomes (13) SD: Standard deviation. P values for leptin and adiponectin were calculated using the Kruskal-Wallis test, and p values for FSIQ scores were calculated using the one-way analysis of variance test. (Ornoy, 2005; Fetita et al., 2006) . We conducted all statistical analyses using SAS version 9.4 (SAS Institute Inc, USA). All hypothesis tests were 2-sided.
Results

Descriptive statistics
In the MIREC Study, 50% of children were males, and 90% were White. In the HOME Study, 46% of the children were males, and 63% were White. Among the 429 children in the MIREC Study, median (25 th ,75 th ) cord plasma leptin and adiponectin concentrations were 11 (5, 23) ng/mL and 15 (9, 22) μg/mL, respectively (Figure S2) . In the HOME Study, 183 children were included in the analysis, with a total of 307 repeated measurements of cognitive abilities at ages 5 and 8 years. Median (25 th ,75 th ) cord serum leptin and adiponectin concentrations were 10 (6, 16) ng/mL and 43 (32, 53) μg/mL, respectively (Figure S2) . In both cohorts, median leptin concentrations were higher among children who were female or had mothers who were overweight or obese (BMI ≥ 25 kg/m 2 ). Median adiponectin concentrations were higher in both cohorts among children who had a mother that was better educated (≥college graduate), or in the HOME Study among children who had a mother that had higher FSIQ. In both cohorts, children's mean FSIQ scores were higher if they were white, breastfed for over 6 months, or born to a mother who was non-obese (BMI ≤ 30 kg/m 2 ), better educated, had higher FSIQ, or had ≤1 previous pregnancy (Tables 1 and 2 ) .
Cord blood adipocytokines and IQ
After adjusting for covariates, cord blood adiponectin was associated with higher FSIQ in both cohorts (MIREC: β = 1.4, 95% confidence interval (CI): 0.2, 2.5, P = 0.02; HOME: β=1.7, CI: -0.1, 3.5, P = 0.06) (Table 3) . Adiponectin was positively associated with children's PIQ in the MIREC Study (β = 2.0, CI: 0.7, 3.3, P < 0.01) and the HOME Study (β=2.2, CI: 0.5, 3.9, P = 0.01). Adiponectin was positively associated with WMI at age 8 years in the HOME Study (β=3.1, CI: 1.0, 5.2, P < 0.01). Adiponectin was not associated with VIQ or PSQ scores. Cord blood leptin was not associated with children's FSIQ or individual IQ components in either study.
Using restricted cubic splines, we observed linear associations of adiponectin with FSIQ, PIQ, and WMI in both studies (all non-linearity P-values≥0.40) ( Figs. 1 and 2 ). There were suggestive inverted Ushaped associations of leptin with FSIQ and most IQ components; however, the non-linearity p-values were not statistically significant (P ≥ 0.11) (Figure S3) .
Results of secondary and sensitivity analyses
Generally, the associations between adipocytokines and cognition did not differ by child sex (Table S1 ). However, leptin was inversely associated with VIQ among boys, but not among girls in the HOME SD: Standard deviation. P values for leptin and adiponectin were calculated using the Kruskal-Wallis test, and p values for FSIQ scores were calculated using the one-way analysis of variance test.
N. Li et al. Psychoneuroendocrinology 99 (2019) 257-264 Study (adipocytokine x sex interaction term P-value = 0.04). Results from sensitivity analyses were not substantially different from main findings, except for attenuation in the associations of adiponectin with FSIQ and PIQ when adjusting for caregiving environment in MIREC Study (Table S2 ).
Discussion
We investigated the associations between cord blood adipocytokine concentrations and children's cognitive abilities in two prospective cohorts. Adiponectin concentrations were positively associated with PIQ and FSIQ in both cohorts. Adiponectin concentrations were positively associated with WMI in the HOME Study. Cord blood leptin concentrations were not associated with children's cognitive abilities in either cohort.
Adiponectin and neurodevelopment
Little is known about the role of adiponectin in neurodevelopment. Adiponectin has multiple functions in peripheral tissues including antiinflammatory and insulin sensitizing effects; some studies suggest adiponectin can cross the blood-brain barrier (Ebinuma et al., 2007; Kos et al., 2007) . Adiponectin receptors are highly expressed in multiple brain regions, including the hypothalamus, cortex, and hippocampus (Fry et al., 2006) . Adiponectin affects hippocampal neurogenesis and stimulates proliferation of hippocampal neural stem cells, and was shown to have neuroprotective effects in animal studies (Nishimura et al., 2008; Jeon et al., 2009; Zhang et al., 2011; Yau et al., 2014; Ng and Chan, 2017) . In addition, lower adiponectin levels may impair cognition by promoting pro-inflammatory cytokines and neuroinflammation (Kasper et al., 2018) .
Two previous studies that investigated the associations between early-life adiponectin and neurobehavioral outcomes found null associations (Camargos et al., 2017; Minatoya et al., 2018) . One study examined behaviors rather than cognition, and found that cord blood adiponectin was not associated with behavior problems among Japanese preschool children (Minatoya et al., 2018) . The other study found that adiponectin concentrations were not associated with cognitive or motor development in 50 Brazilian infants at ages 6-24 months (Camargos et al., 2017) . There are two possible reasons for the discrepancies. First, the Japanese study examined children's behavior, whereas our study assessed cognitive abilities, which may not be correlated with behavioral outcomes. Moreover, we assessed several domains of cognitive abilities in children at age 3-8 years, but the Brazilian study used a global measure of cognitive abilities in infancy, and not any specific domains (Bayley, 2006) . Thus, the Brazilian study may not have been able to observe associations between adiponectin and more specific cognitive domains that can be assessed later in childhood. Second, the Brazilian study was cross-sectional, examining infant plasma adiponectin concentrations and cognition at the same time. Given that adiponectin level changes with age and other factors (Erhardt et al., 2014; Gruszfeld et al., 2016) , the adiponectin concentrations measured in infancy may not represent fetal adiponectin concentrations. In contrast, we prospectively investigated the long-term impact of cord blood adiponectin on childhood cognition.
Leptin and neurodevelopment
Leptin is important for the formation of normal brain structure and development of brain functions in the fetus (Udagawa et al., 2007) . Leptin has receptors expressed in multiple brain regions involved in cognition, and it plays an important role in hippocampal-based learning and memory processing (Farr et al., 2006; Oomura et al., 2006; Morrison, 2009 ). However, high plasma leptin levels promote pro-inflammatory responses, which may lead to neuroinflammation and cognitive deficits (Calabrese et al., 2014) . In our study, leptin was not associated with cognitive abilities. However, we observed suggestive inverted U-shaped associations of leptin with FSIQ and most IQ components, where scores increased, peaked, and then decreased with increasing leptin concentrations (Figure S3) . Therefore, we speculate that the inverted U-shaped relation between leptin and cognitive scores in these data may represent an optimal level of fetal leptin necessary for proper neurodevelopment.
Previous studies examining the association between fetal leptin and neurobehavior are inconclusive. One study found that higher placental leptin methylation (i.e., reduced leptin gene expression) was associated with increased risk of lethargy and hypotonicity among boys (Lesseur et al., 2014) . Among Japanese preschool children, cord blood leptin was inversely associated with hyperactivity/inattention (Minatoya et al., 2018) . In validating the WPPSI-III, the developers reported that children with attention deficit hyperactivity disorder had slightly lower FSIQ and PIQ scores compared to their matched controls, but the differences were not statistically significant (Wechsler, 2003) . Therefore, it is not surprising that we did not observe an association between cord blood leptin and children's FSIQ. Given that cognitive abilities may be correlated with certain behaviors, future studies could examine the consistency of the associations of cord blood adipocytokines with cognitive abilities and behaviors.
The Brazilian study reported that plasma leptin concentrations were inversely associated with cognitive scores among 6-24 month old infants (Camargos et al., 2017) . It is noteworthy that 50% of the infants in this study were overweight or obese, and they had higher leptin concentrations (Camargos et al., 2017) . Therefore, the observed inverse association may have been driven by children with higher BMI, who have a different dose-response relationship for the leptin-cognition association compared to children with lower BMI (Otero et al., 2006; Calabrese et al., 2014) .
Limitations
One limitation of our study is that we only measured adipocytokine concentrations at birth. Given that there are changes in adipocytokine concentrations and neurodevelopment during the pre-and postnatal periods, future studies should consider examining trajectories of adipocytokine concentrations from birth to childhood in relation to children's cognitive abilities (Erhardt et al., 2014; Gruszfeld et al., 2016) . Moreover, we cannot exclude the possibility of residual confounding, even though both studies had rich sets of covariate data. Specifically, maternal IQ was not measured in the MIREC Study. However, we adjusted for maternal education, a surrogate for maternal IQ. There is also the possibility of residual confounding from other biomarkers that are correlated with adiponectin (e.g., other adipocytokines) (Mantzoros et al., 2010) . The median adiponectin concentrations were 15 μg/mL in the MIREC Study and 43 μg/mL in the HOME Study, which are comparable with median adiponectin concentrations reported in previous studies (15-76 μg/mL) (Sivan et al., 2003; Mantzoros et al., 2009; Meyer et al., 2017; Simpson et al., 2017) . The differences in the concentrations across the present cohorts may be partly explained by differences in specificity characteristics of immunoassays for various adiponectin oligomers (Pajvani et al., 2003; Tabara et al., 2008; Melmed et al., 2011) and different matrices used for adiponectin measurement (cord serum vs. cord plasma) (Yu et al., 2011) . Finally, it is possible that fetal or childhood adiposity could mediate the association between adiponectin and cognition. While adiponectin plays a role in regulating metabolism and childhood adiposity is related to cognitive abilities (Li et al., 2018) , studies investigating the associations of cord blood adiponectin with birth weight and childhood growth are inconsistent (Lindsay et al., 2003; Mantzoros et al., 2009; Zhang et al., 2016) . However, when we adjusted for birth weight or children's BMI at the time of cognition assessment, our results were essentially unchanged, suggesting that neither birth weight nor children's BMI is a mediator of the association between adiponectin and cognition.
Strengths
Our study had several strengths. We used data from two prospective cohorts. Compared to the cross-sectional design in the previous studies, the prospective design enabled us to examine the long-term association of cord blood adipocytokines, representing the prenatal period, with children's cognitive abilities from ages 3-8 years. Moreover, despite the Concentrations (on log 2 -scale), and Children's Full-Scale IQ, Performance IQ at ages 3, 5 or 8 Years a . a IQ was assessed at approximately age 3 years in the MIREC Study, and at ages 5 and 8 years in the HOME Study. In the MIREC Study, we adjusted for continuous variables maternal age, and length of breastfeeding; and categorical variables maternal education (high school graduate or less, tech school or some college, college graduate or above), pre-pregnancy BMI (< 25, ≥25 kg/ m 2 ), parity number (0, 1, ≥2), marital status (married, unmarried), child's sex (Male, Female), and race (White, other). In the HOME Study, we adjusted for continuous variables maternal age and IQ, children's age at outcome assessment; and categorical variables maternal education (high school graduate or less, tech school or some college, college graduate or above), marital status (married, unmarried), pre-pregnancy BMI (< 25, ≥25 kg/m 2 ), parity number (0, 1, ≥2), duration of breastfeeding (never, 0-6 month, > 6 month), child's sex (Male, Female), and race (non-Hispanic White, non-Hispanic Black, other).
Fig. 2. Adjusted Restricted Cubic Polynomial Spline of Cord Blood Adiponectin.
Concentrations (on log 2 -scale) and Children's Working Memory score at age 8 Years a . a In the HOME Study, we adjusted for continuous variables maternal age and IQ, children's age at outcome assessment; and categorical variables maternal education (high school graduate or less, tech school or some college, college graduate or above), marital status (married, unmarried), pre-pregnancy BMI (< 25, ≥25 kg/m 2 ), parity number (0, 1, ≥2), duration of breastfeeding (never, 0-6 month, > 6 month), child's sex (Male, Female), and race (non-Hispanic White, non-Hispanic Black, other). demographic differences in the source populations, results from the two studies were consistent and the effect sizes were comparable, which strongly supports the robustness of our findings. Furthermore, children's overall intellectual abilities and individual IQ components were assessed using valid and reliable tests. Additionally, we collected detailed covariate information in both cohorts, which enabled us to adjust for many potential confounding factors. Finally, by demonstrating associations of adiponectin with children's PIQ and FSIQ scores at different ages, our results suggest a possible long-term impact of cord blood adipocytokines on childhood cognition.
Conclusions
In conclusion, these results provide new insights into factors that affect the fetal programming of neurodevelopment. Specifically, cord blood adiponectin concentrations were positively associated with several aspects of children's cognitive abilities in two prospective cohorts from North America. Future studies should confirm these findings, and laboratory or molecular epidemiology studies are needed to explore the underlying biological mechanisms. If our findings are confirmed, there is the potential to improve children's IQ by intervening on modifiable factors that influence cord blood adiponectin levels, such as first trimester gestational weight gain and maternal protein intake (Mantzoros et al., 2010; Rifas-Shiman et al., 2017) . 
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